ORCHPHARMA — Orchid Pharma Balance Sheet
0.000.00%
- IN₹42.26bn
- IN₹43.58bn
- IN₹9.22bn
- 35
- 10
- 36
- 12
Annual balance sheet for Orchid Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 350 | 80.6 | 308 | 2,711 | 1,827 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,902 | 2,231 | 2,161 | 1,972 | 2,445 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,499 | 4,499 | 5,010 | 7,908 | 8,074 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,775 | 5,931 | 6,192 | 6,360 | 6,964 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,373 | 11,106 | 12,252 | 15,539 | 16,879 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,421 | 2,408 | 3,719 | 2,600 | 2,856 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,843 | 4,632 | 5,366 | 3,844 | 4,206 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 6,529 | 6,474 | 6,886 | 11,695 | 12,673 |
| Total Liabilities & Shareholders' Equity | 12,373 | 11,106 | 12,252 | 15,539 | 16,879 |
| Total Common Shares Outstanding |